|
Targeting Treatment For ADAM30 In Pathological Cells
Reference #: 01462
The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells
Background:
The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...
Published: 7/10/2026
|
Updated: 5/7/2021
|
Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao
Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation
Category(s): Health Sciences, Biomedical and Life Sciences
|